BALT

Executive Summary

BALT is a French medical device company founded in 1977, specializing in neurovascular interventions for stroke treatment. With a strong legacy of physician-inspired innovation, the company develops and manufactures devices for both ischemic and hemorrhagic stroke. It is now expanding its technology platform into the peripheral vascular space, aiming to diversify its revenue streams and address larger market opportunities. As a private entity with decades of experience, BALT holds a respected position in the neurovascular niche, though limited public financial data makes detailed assessment challenging.

Upcoming Catalysts (preview)

• TBDLaunch of peripheral vascular product line70% success
• TBDNew regulatory approvals for neurovascular devices in major markets75% success